CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 43,125 shares (option exercise)
- 4 Open-market buy President and CEO bought 3,200 shares at $3.02 ($9,664)
- 4 Open-market buy President and CEO bought 13,800 shares at an average $2.85 ($39,387)
- 4 Open-market buy Chief Medical Officer bought 2,000 shares at $2.85 ($5,698)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition President and CEO acquired 12,020 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Medical Officer bought 50,000 shares at an average $2.82 ($141,002)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 24 of 36 · 701 filings